Navigation Links
DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
Date:11/14/2013

>Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K. We do not undertake to update these forward-looking statements made by us.

For further information, please visit www.delmarpharma.com.


'/>"/>
SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/14/2014)... (Nasdaq: LMNX ) today announced that it expects ... Monday, February 3, 2014. A press release announcing the results ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the fourth quarter and twelve months ended ...
(Date:1/14/2014)... Critical Care, a LifeCentre partner practice, located at 165 Fort Evans ... in Loudoun County to receive a small ... Barnes , Medical Director, is a well-seasoned veterinarian of more than ... are avid scuba divers. "As altitude skiers and hikers, we recognize ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... Medical Alarm Concepts Holding, Inc. (OTC Bulletin Board: MDHI), manufacturer ... you to speak and listen directly through the pendant, announced today ... grocery stores. , , ... Under the terms of the distribution agreement signed in March of ...
... BEIJING , July 13 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems,Ltd. ... and sale of medical devices and homecare medical products in ... line,(QS-100A series) from Beijing Qiumanshi Technology Co., Ltd. The acquisition,includes the ... , , ...
Cached Medicine Technology:Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons 2Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons 3Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 2Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 3Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 4
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently received ... in metastatic breast cancer reduces both the growth of ... scientists have found in models of the disease that ... 80 percent and can keep the tumor from metastasizing ... grant comes from the National Cancer Institute of the ...
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
(Date:4/17/2014)... University of California, San Diego School of Medicine report ... suffered a recent major loss are more likely to ... The study is published in this month,s issue of ... Because compassionate behaviors are associated with better health and ... into ways to improve the outcomes of individuals whose ...
(Date:4/17/2014)... University synthetic biology team has created a new ... therapeutics that could travel the body and selectively ... Engineering cell-based, biological devices that monitor and modify ... synthetic biology. However, no existing technology enabled bioengineers ... physiological state and respond in a customized fashion. ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2
... send more than 26,000 rushing in for acute care each ... Gymnastics done well is graceful and awe-inspiring, but one misstep ... than 26,000 American children end up in hospital emergency rooms ... study in the April issue of Pediatrics . , ...
... Campaign Urges Patients to Take an Active Role ... 4, 2008 ,Understanding the often complex medical information ... be difficult, and the consequences of,misunderstanding this information ... is launching a national campaign to help Americans,prevent ...
... 2008 Terumo Cardiovascular,Systems (Terumo CVS) announced yesterday ... by Maquet Cardiovascular LLC. The complaint alleges,that Terumo ... infringed,on two patents related to the sale of ... http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ), Terumo CVS states ...
... 32, Injured Twice,in the Line of Duty, MIDDLE ISLAND, ... SCOOTER Store:, WHO: Kevin O,Connor, 32, Middle Island resident, ... John Feal, President, The FealGood Foundation and benefit organizer, ... County Legislator John M. Kennedy Jr, Anthony Pepe, a ...
... employers to abandon benefits, study finds , , FRIDAY, April 4 ... for employees increased more for small U.S. businesses than for ... businesses have not stopped offering the benefit, a new study ... of more than 2,500 small, medium and large companies found ...
... April 4, 2008 SurgiQuest, Inc. today,announced the ... access system., At Baystate Medical Center, Springfield, ... performed a gallbladder removal procedure,through a single 12mm ... system creates an invisible barrier that does not ...
Cached Medicine News:Health News:Young Gymnasts Tumbling and Vaulting Their Way to the ER 2Health News:Young Gymnasts Tumbling and Vaulting Their Way to the ER 3Health News:'Understanding Your Caregivers' Promotes Health Literacy 2Health News:'Understanding Your Caregivers' Promotes Health Literacy 3Health News:Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement 2Health News:Small Firms Shoulder Burden of Increasing Health Costs 2Health News:SurgiQuest Announces First Procedure Using AirSeal(TM) Access System 2
... Model 6491 unipolar pediatric temporary ... temporary atrial and ventricular sensing ... cardiac surgery. This temporary pacing ... it the ideal lead for ...
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
... PY series leads are implantable bipolar ... stimulation of either the atrium or ... screw can be extended or retracted ... lead tip contains an anti-chattering mechanism ...
Used to occupy an empty hole which is not being used in an implantablepacemaker header....
Medicine Products: